Our results, shown in Fig. 9a-b, demonstrated that classifiers incorporating factors such as FAB, age, FANCI, FAAP100 expression, and others contribute to cytogenetic risk classification in AML patients. The gene discussed is FANCB; the disease is acute myeloid leukemia.